Abiopharma

Kaiser Peter 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001291

ANDO GORAN 🟢 acquired 41.5K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

📋 Frates James M (Officer) plans to sell 3K shares of Amylyx Pharmaceuticals, Inc. (at $11.11 each, total $37K) Filed: Jan 06, 2026 | ID: 004407

Fortress Biotech, Inc. 🟢 acquired 111.2K shares of AVENUE THERAPEUTICS, INC. (ATXI) Transaction Date: Jan 02, 2026 | Filing ID: 000004

Director Lindborg Stacy 🟢 acquired 56.2K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000604

Nuvation Bio Inc. - Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference

Biodexa Pharmaceuticals PLC (BDRX) Files Form 6-K

Bjork Elisabeth 🟢 acquired 10.0K shares of ROCKET PHARMACEUTICALS, INC. (RCKT) at $3.44 Transaction Date: Jan 02, 2026 | Filing ID: 000378

Susi Roger E. 🔴 sold 5.0K shares of IRADIMED CORP (IRMD) at $99.48 Transaction Date: Jan 05, 2026 | Filing ID: 000002

Smith Michael Alexander 🟢 acquired 32.9K shares (1 derivative) of INSMED Inc (INSM) at $177.12 ($4.9M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results

ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026

Saroj Namrata 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001288

📋 Cohen Joshua B (Officer) plans to sell 8K shares of Amylyx Pharmaceuticals, Inc. (at $11.09 each, total $86K) Filed: Jan 06, 2026 | ID: 004394